摘要
目的:分析肺炎支原体感染后咳嗽采取布地奈德雾化吸入治疗的疗效。方法:随机选择2015年2月~2017年2月在某院接受治疗的肺炎支原体感染后咳嗽患者120例参与研究,按照患者入院的先后顺序一对一分组,参照组60例患者行常规治疗,研究组60例患者行布地奈德雾化吸入治疗,比较两组治疗效果。结果:研究组患者临床疗效、咳嗽症状评分、住院时间、咳嗽消失时间均明显优于参照组(P<0.05)。结论:对肺炎支原体感染后咳嗽患者实施布地奈德雾化吸入治疗,能够显著改善患者症状,临床价值显著。
Objective:To analyze the curative effect of budesonide atomization inhalation for coughing af- ter mycoplasma pneumoniae infection.Methods: 120 cases patients with coughing after mycoplasma pneumoniae infection treated in a hospital from February'2015 to February 2017 were randomly selected and divided into control group and study group according to the order of admission,with 60 cases in each group.The con- trol group was given routine therapy,and the study group was given budesonide atomization inhalation treatment,then the therapeutic effects of two groups were compared. Results: The clinical curative effect, cough symptom score, hospitalization time and coughing disappearance time of the study group were obviously su- perior to those of the control group (P〈0.05).Conclusion: The treatment of budesonide inhalation for patients with mycoplasma pneumoniae infected cough can significantly improve the symptoms of the patients, with significant clinical value.
出处
《数理医药学杂志》
2018年第1期95-96,共2页
Journal of Mathematical Medicine
关键词
肺炎支原体感染
咳嗽
布地奈德
雾化吸入
疗效
mycoplasma pneumoniae infection
cough
budesonide
aerosol inhalation
curative effect